Silver Book Fact

Fact image

Medicines in Devlopment for Cancer, 2008

PhRMA. 2008 Report: Medicines in Development for Older Americans; November 2008

Reference

Title
2008 Report: Medicines in Development for Older Americans
Publication Date
November 2008
Authors
PhRMA

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Thousands of potential cancer medicines in development
     
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • Percentage of women age 50 and over who had a mammogram in the past 2 years, by age group, selected years 1987-2005  
  • Incidence rates for colorectal cancer have been decreasing since 1985, from 66 to 52 per 100,000 in 2002.  
  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.